4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-23-093070
Sr. VP and CFO acquired 201,903 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rubin Eyal Sr. VP and CFO | 2023-08-15 | Grant or award | +201,903 | 570,000 | I |
Loading xslF345X05/tm2324046-3_4seq1.xml…